Data as of Q4 2025 (Dec 31, 2025)

Celularity Inc.

(CELU)

Financial Statements · SEC EDGAR XBRL

Revenue
$26.6M
-51.0%
Net Income
-$91.7M
-58.4%
EPS
$-3.59
-36.0%
Gross Margin
24.4%
Op. Income
-$61.3M
-59.8%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Selling General & Admin
Research & Development
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
$26.6M
$54.2M
$22.8M
$18.0M
$21.3M
$26.6M
$54.2M
$22.8M
$18.0M
$21.3M
$20.1M
$15.0M
$16.0M
-
-
$6.5M
$39.2M
$6.8M
-$1.7M
$11.7M
$51.3M
$58.6M
$50.6M
$66.0M
$71.3M
$15.0M
$17.4M
$30.5M
$78.4M
$88.4M
-$61.3M
-$38.4M
-$192.3M
-$25.6M
-$109.1M
-$30.4M
-$19.5M
-$4.0M
$39.8M
$9.0M
-$91.7M
-$57.9M
-$196.3M
$14.2M
-$100.1M
$3K
-
$10K
$13K
$20K
-$91.7M
-$57.9M
-$196.3M
$14.2M
-$100.1M
$-3.59
$-2.64
$-11.02
$1.01
$-1.49
$-3.59
$-2.64
$-11.02
$0.95
$-1.49
25.6M
21.9M
17.8M
15.0M
67.1M